Francis Paul Worden
Nancy Wigginton Oncology Research Professor of Thyroid Cancer
Clinical Professor of Internal Medicine, Medical School
Available to mentor
Francis Paul Worden
Clinical Professor
Manage Your Profile
Center Memberships
-
Center MemberRogel Cancer Center
Recent Publications
-
Pearson AT, Muzaffar J, Kirtane K, Bellile E, Suresh K, Rosenberg AJ, Worden F, Chung CH, Vokes E, Brenner JC, Bhangale A, McHugh J, Warner K, Nor F, Nor JE, Innes K, Zhai Y, Fu T, Swiecicki PL. Nature Communications, 2026 Dec 1; 17 (1):Journal ArticleMDM2 Inhibition with Alrizomadlin (APG-115) in TP53 wild-type salivary gland cancers: a phase I clinical trial
DOI:10.1038/s41467-026-70653-3 PMID: 41857036 -
Gu W, Bhangale AD, Du X, Deng X, Gensterblum-Miller EU, Currie J, Brummel CV, Nyabashi V, Buchakjian M, Casper KA, Chinn SE, Forner D, Malloy KM, Mierzwa ML, Prince ME, Shah JL, Shuman AG, Stucken CL, Swiecicki PL, Worden FP, Yalamanchi P, McHugh JB, Lang Kuhs KA, Boyle AP, Jiang H, Heft Neal ME, Spector ME, Mills RE, Brenner JC. 2026 Oct 10;PreprintSpatiotemporal Heterogeneity of HPV Integration Architectures Drive Oncogenic Features of Oropharyngeal Cancer.
DOI:10.64898/2026.10.03.756294 PMID: 42926491 -
Higgins L, Suresh K, Wilkins S, Lyden T, Blakely A, Ambrose M, Elliott DA, Strohbehn G, Prince ME, Casper K, Shuman A, Stucken CL, Forner D, Heft-Neal ME, Yalamanchi P, Brenner C, Swiecicki PL, Worden F, Mierzwa ML, Shah JL. International Journal of Radiation Oncology • Biology • Physics, 2026 Sep 27; 126 (1): e689 - e690.Proceeding / Abstract / PosterTwelve-Month Swallowing Outcomes in a Phase II Trial of PET-Adapted Radiation for HPV-Associated Oropharynx Squamous Cell Carcinoma
DOI:10.1016/j.ijrobp.2026.06.2147 -
Higgins L, Suresh K, Shah JL, Nasser B, Casper K, Prince ME, Forner D, Buchakjian M, Heft-Neal ME, Yalamanchi P, Rosen BS, Shuman A, Stucken CL, Brenner C, D'Silva N, Swiecicki PL, Worden F, Mierzwa ML. International Journal of Radiation Oncology • Biology • Physics, 2026 Sep 27; 126 (1): e689Proceeding / Abstract / PosterUMCC 2023.006: A Pilot Phase II Trial of Individualized FDG-PET and DCE-MRI Directed Adaptive RT in HPV-related Stage III Oropharynx Cancer
DOI:10.1016/j.ijrobp.2026.06.2146 -
Coyle AH, Hutton DW, Buchakjian MR, Casper KA, Forner DW, Hawley ST, Heft Neal ME, Malloy KM, Mierzwa ML, Prince ME, Shah JL, Sweicicki PL, Shuman AG, Stucken CL, Veenstra CM, Worden FP, Yalamanchi P. JAMA Otolaryngology Head and Neck Surgery, 2026 Sep 1; e262124 - e262124.Journal ArticleCombined Positive Score and Cost-Effectiveness of Perioperative Pembrolizumab for Head and Neck Cancer. Epub ahead of print
DOI:10.1001/jamaoto.2026.2124 -
Saba NF, Ismaila N, Adkins D, Agrawal N, Akhave N, Blomain ES, Cabanillas ME, Chen A, Galloway TJ, Harada G, Li D, Noureldine SI, Scharpf J, Sun LL, Tang M, Wirth L, Worden F, Zandberg DP, Beadle BM. Journal of Clinical Oncology, 2026 May 10; 44 (14): 1349 - 1372.Journal ArticleSystemic Treatment of Thyroid Cancer: ASCO Guideline
DOI:10.1200/JCO-26-00235 PMID: 41921121 -
Bruce JY, Fujioka N, Worden F, Mehra R, Laux D, Chae YK, Sulahadeen A, Pease D, Cao Q, Kimple R, Garcia A, Patel MR. International Journal of Radiation Oncology • Biology • Physics, 2026 Apr 18; 125 (1): e23Journal ArticleBTCRC HN17-111: A Phase 2 Trial of Androgen Deprivation Therapy (ADT) and Pembrolizumab for Treatment of Advanced-Stage Androgen Receptor (AR)-Positive Salivary Gland Carcinoma
DOI:10.1016/j.ijrobp.2026.02.046 -
Risch Z, Bellile E, Bughrara MS, Swiecicki PL, Casper K, Malloy K, Hogikyan N, Spector M, Shuman A, Stucken C, Chinn S, Chepeha DC, Jolly S, Mierzwa M, Bradford C, Eisbruch A, Carey T, Prince M, Wolf GT, Worden FP. Head and Neck, 2026 May 1; 48 (5): 1311 - 1318.Journal ArticleNeutrophil to Lymphocyte and Lymphocyte to Monocyte Ratios Predict Improved Survival and Response to Induction Chemotherapy in Locally Advanced Squamous Cell Carcinoma of the Larynx
DOI:10.1002/hed.70132 PMID: 41403153